Again, the FDA lies about Leronlimab showing any benefit for critical COVID-19 patients. Absolutely no credit given for when the drug was in their system. We know what Nader was referring to. This is just another cheap shot!
Where are we, on the Brazil trials? We need an update!
On a personal note; I hope Phil rots in h3ll!